MG217 cream recall issued over potential staph contamination risk

On 2026-05-14, the U.S. Food and Drug Administration announced a nationwide recall of MG217 Multi-symptom Treatment Cream & Skin Protectant Eczema Cream due to potential Staphylococcus aureus contamination. The affected product was lot 1024088 with an expiration date of November 2026 and was distributed nationwide.